ARIXTRA
Live / Registered — Registered and renewed (as of 28 Nov 2023)
What this means for you
Registered since 16 Mar 2004. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 16 Mar 2024).
Record
- Serial number
- 76251411
- Registration number
- 2823751
- Mark type
- Design + words
- Filed
- 04 May 2001
- Published for opposition
- 09 Oct 2001
- Registered
- 16 Mar 2004
- Next maintenance due
- 16 Mar 2024
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical products for the prevention and for the treatment of cardiovascular diseases or disorders
- Class 010 — Medical apparatus: syringes for medical use
Owner
- MYLAN INSTITUTIONAL INC., ROCKFORD, IL, US
- MYLAN IRELAND LTD., DUBLIN, IE
- ASPEN GLOBAL INCORPORATED, Port Louis, MU
- Glaxo Group Limited, Brentford, Middlesex, GB
- Sanofi-Synthelabo, 75013 Paris, FR
- Sanofi-Synthelabo, 75013 Paris, FR
- Sanofi-Synthelabo, 75013 Paris, FR
Prior registrations
Prosecution history
- 28 Nov 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 28 Nov 2023 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 28 Nov 2023 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 28 Nov 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 01 Jun 2023 — TEAS SECTION 8 & 9 RECEIVED
- 16 Mar 2023 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 05 Dec 2018 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 21 Nov 2018 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 13 Nov 2018 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 13 Nov 2018 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 11 Sept 2014 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 11 Sept 2014 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 11 Sept 2014 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 11 Sept 2014 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 29 Aug 2014 — TEAS SECTION 8 & 9 RECEIVED